Monte Rosa Therapeutics, Inc. (GLUE)
16.56
-0.67
(-3.89%)
USD |
NASDAQ |
Dec 11, 16:00
16.57
+0.01
(+0.06%)
Pre-Market: 08:19
Monte Rosa Therapeutics Free Cash Flow: 145.02M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Novartis AG | 17.15B |
| AVITA Medical, Inc. | -36.58M |
| NanoVibronix, Inc. | -7.281M |
| Mirum Pharmaceuticals, Inc. | 44.32M |
| Day One Biopharmaceuticals, Inc. | -124.86M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 100.43M |
| Cash from Investing (Quarterly) | 38.14M |
| Cash from Financing (Quarterly) | 0.348M |
| Free Cash Flow Per Share (Quarterly) | 1.211 |
| Free Cash Flow to Equity (Quarterly) | 100.74M |
| Free Cash Flow to Firm (Quarterly) | 99.78M |
| Free Cash Flow Yield | 11.33% |